68180-355 : Ranolazine 1000 mg Oral Tablet, Film Coated, Extended Release


NDC68180-355
Labeler: Lupin Pharmaceuticals, Inc.
Product Type: Human Prescription Drug
Drug Name:  Ranolazine
Dosage Form: Oral Tablet, Film Coated, Extended Release
Application #: ANDA201046
Rev. Date: 


NDC Package Codes:

  • 68180-355-02: 500 TABLET, FILM COATED, EXTENDED RELEASE IN 1 BOTTLE (68180‑355‑02)
  • 68180-355-07: 60 TABLET, FILM COATED, EXTENDED RELEASE IN 1 BOTTLE (68180‑355‑07)

Active Ingredients:

  • Ranolazine

Dosage Strength:

  • 1000 mg

Pharmaceutical Classes:

  • Anti-anginal [EPC]
  • Cytochrome P450 3A Inhibitors [MoA]
  • P-Glycoprotein Inhibitors [MoA]
  • Cytochrome P450 2D6 Inhibitors [MoA]
  • Organic Cation Transporter 2 Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 68180-354 Ranolazine 500 mg Oral Tablet, Film Coated, Extended Release by Lupin Pharmaceuticals, Inc.
  • 27241-125 Ranolazine 500 mg Oral Tablet, Extended Release by Ajanta Pharma Limited
  • 27241-126 Ranolazine 1000 mg Oral Tablet, Extended Release by Ajanta Pharma Limited
  • 43975-289 Ranolazine 1 g/1 Oral Tablet, Extended Release by Amerigen Pharmaceuticals Inc.
  • 43975-290 Ranolazine 500 mg Oral Tablet, Extended Release by Amerigen Pharmaceuticals Inc.
  • 45963-418 Ranolazine 500 mg Oral Tablet, Film Coated, Extended Release by Actavis Pharma, Inc.
  • 45963-419 Ranolazine 1000 mg Oral Tablet, Film Coated, Extended Release by Actavis Pharma, Inc.
  • 50228-423 Ranolazine 500 mg Oral Tablet, Film Coated, Extended Release by Sciegen Pharmaceuticals, Inc
  • 50228-424 Ranolazine 1000 mg Oral Tablet, Film Coated, Extended Release by Sciegen Pharmaceuticals, Inc
  • 51407-225 Ranolazine 500 mg Oral Tablet, Film Coated, Extended Release by Golden State Medical Supply Inc.
  • 51407-226 Ranolazine 1000 mg Oral Tablet, Film Coated, Extended Release by Golden State Medical Supply Inc.
  • 60687-460 Ranolazine 500 mg Oral Tablet, Film Coated, Extended Release by American Health Packaging
  • 63304-017 Ranolazine 500 mg Oral Tablet, Extended Release by Sun Pharmaceutical Industries, Inc.
  • 63304-018 Ranolazine 1000 mg Oral Tablet, Extended Release by Sun Pharmaceutical Industries, Inc.
  • 68462-319 Ranolazine 500 mg Oral Tablet, Film Coated, Extended Release by Glenmark Pharmaceuticals Inc., USA
  • 68462-320 Ranolazine 1000 mg Oral Tablet, Film Coated, Extended Release by Glenmark Pharmaceuticals Inc., USA
  • 69097-221 Ranolazine 500 mg Oral Tablet, Film Coated, Extended Release by Cipla USA Inc.
  • 69097-222 Ranolazine 1000 mg Oral Tablet, Film Coated, Extended Release by Cipla USA Inc.
  • 70771-1499 Ranolazine 500 mg Oral Tablet, Extended Release by Cadila Healthcare Limited
  • 70771-1500 Ranolazine 1000 mg Oral Tablet, Extended Release by Cadila Healthcare Limited
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 68180-355 QR Code

< Prev: 68180-354Next: 68180-360 >

Related Discussions:

Ranolazine 500mg
My mother is 65 years old, consuming Ranolazine - but i dont know what for? Please advise me. ## Ranolazine, the active ... 3 replies
can Nikoran be used with ranolazine
In refractory angina after angioplasty what should be treatment guidelines ## I'm using nicorandil 10mg twice daily ... 1 reply
Ranolazine for SOB
I am 82 now. When I walk some distance I get heavy breathing. Indoors I am perfectly ok. CT angiogram and ECG normal. No...




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 10 May 2019.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA